Related Experiment Videos
Acquired and congenital risk factors associated with cerebral venous sinus thrombosis
Robert D McBane1, Alfonso Tafur, Waldemar E Wysokinski
1Division of Cardiovascular Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA. mcbane.robert@mayo.edu
Insights
Cerebral venous sinus thrombosis is an exception to typical venous thrombosis causes, often linked to female-specific factors and genetic mutations. Understanding these risk factors is key for clinical management and preventing recurrence.
Area of Science:
- Neurology
- Hematology
- Genetics
Background:
- Venous thrombosis typically arises from local organ system pathology.
- Cerebral venous sinus thrombosis (CVST) presents an exception, with diverse underlying causes.
- A significant female predilection and association with hormonal factors are observed in CVST.
Purpose of the Study:
- To review acquired and congenital risk factors for cerebral venous sinus thrombosis.
- To aid clinicians in identifying underlying mechanisms of CVST.
- To assist in risk stratification for anticoagulation and recurrence prediction.
Main Methods:
- Comprehensive literature review of acquired and congenital risk factors for CVST.
- Analysis of epidemiological data and genetic predispositions.
- Synthesis of clinical observations regarding hormonal influences and thrombosis.
Main Results:
- CVST etiology is multifactorial, involving both acquired and inherited risk factors.
- Hormonal manipulation, pregnancy, and the puerperium are significant risk factors in women.
- Genetic factors like Factor V Leiden and prothrombin G20210A mutations, alongside hyperhomocysteinemia, contribute to CVST risk, especially when combined with acquired factors.
Conclusions:
- CVST pathogenesis is complex and distinct from typical venous thrombosis.
- Identifying specific risk factors is crucial for targeted clinical management and patient counseling.
- Further research into the interplay of genetic and hormonal factors may elucidate CVST mechanisms and improve treatment strategies.
Abstract:
The mechanistic paradigm underlying venous thrombosis at atypical locations stems from the observation that most events occur as a result of pathology of the organ system drained by the involved venous segment. Cerebral venous sinus thrombosis stands apart as an exception to this general rule. Although brain and sinus pathology are well established causes, these combined variables account for approximately one third of cases. The marked female preponderance and strong association with gender specific risk factors including hormonal manipulation, pregnancy and the puerperium are particularly notable. Factor V Leiden and prothrombin G20210A mutations and hyperhomocysteinemia represent important risk factors particularly when combined with acquired variables. The association with oral contraception use and the prothrombin G20210A gene mutation may offer insights into the anatomic predilection for cerebral venous sinus involvement as compared to venous thrombosis of the lower extremities. The intent of this review is to summarize the corporate literature of both acquired and congenital risk factors associated with cerebral venous sinus thrombosis in order to assist clinicians in their search for underlying mechanisms and to risk stratify patients for anticoagulation treatment duration and risk of recurrent thrombosis.
Related Concept Videos
Venous Thrombosis I: Introduction
Hemorrhagic Stroke l: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins I: Introduction
Cerebral Edema ll: Pathophysiology
Increased Intracranial Pressure l: Introduction